Centessa Pharmaceuticals
United StatesEntry
2021
Hold
5yr
Status
Active
Who owns Centessa Pharmaceuticals?
Centessa Pharmaceuticals is an American Biotech company, currently owned by IP Group since 2021 and General Atlantic.
Hand-verified · updated 2026-04-21
Open JSON · CC-BY
Most recent investor
General AtlanticGeneral Atlantic · 2020 · Growth
2 ownership periods · full history below
Key facts
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2021 · present
IP GroupActive
2021 · present(5yr) · IP Group (Evergreen) · 2001 · Evergreen
General AtlanticActive
2021 · present(5yr) · General Atlantic · 2020 · Growth
More from General Atlantic
Other portfolio companies in the same fund.
UKMore PE-backed in Biotech
Comparable biotech deals from other GPs.
GermanyQuestions
Who owns Centessa Pharmaceuticals?
Centessa Pharmaceuticals is currently owned by IP Group and General Atlantic, through General Atlantic, since 2021.
When did IP Group and 1 other acquire Centessa Pharmaceuticals?
IP Group and 1 other acquired Centessa Pharmaceuticals in 2021.
Who has owned Centessa Pharmaceuticals over time?
Centessa Pharmaceuticals has been through 2 private-equity ownership periods: IP Group · via IP Group (Evergreen) · since 2021; General Atlantic · via General Atlantic · since 2021.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue